Connect with us

FDA CDC News

Ba-kawk! UPSIDE Foods Pens Open Letter to Chickens to Mark Historic US FDA “Green Light” for Cultivated Meat

 To celebrate a world-first regulatory milestone that brings the future of food one step closer to U.S. consumers, UPSIDE is sharing the news with those who will benefit most: chickens

Published

on

 To celebrate a world-first regulatory milestone that brings the future of food one step closer to U.S. consumers, UPSIDE is sharing the news with those who will benefit most: chickens

BERKELEY, Calif. /PRNewswire/ — To commemorate a groundbreaking regulatory milestone for UPSIDE Foods and for the future of food, UPSIDE Foods founder and CEO Uma Valeti published an open letter in today’s New York Times to those who will benefit most from the news: chickens. UPSIDE Foods is the leading cultivated meat, poultry, and seafood company and grows delicious meat directly from animal cells.

Valeti — a trained cardiologist and life-long animal lover — addressed the chickens of the world in their native bawk-filled language. He announced that UPSIDE Foods is the first company in the world to receive a “No Questions” letter from the U.S. Food and Drug Administration (FDA). This means that after a rigorous evaluation, FDA has accepted UPSIDE’s safety conclusion. UPSIDE’s first product will be a chicken filet, and it will be available following USDA inspection and label approval. “The affirmation from FDA is a watershed moment in the history of food,” says Valeti, “and an even bigger moment for chickenkind.”

In the Times open letter, Valeti wrote, “In the future, we might be eating just as much meat as we always have. But a lot fewer animals are going to have to suffer for it. We wanted you, the chickens of the world, to be the first to know. And we hope it brings a smile to your beaks.”  Read the full English translation at upsidechickenletter.com.

UPSIDE Foods selected chicken as its first commercial offering because it’s the most commonly eaten meat in the U.S. and is quickly becoming the meat of choice for consumers around the world.  Every year, Americans consume an estimated 8 billion chickens — or roughly 100 pounds per person — a number that has doubled since the 1970s. This growth in demand has been accompanied by an exponential increase in high-intensity industrial chicken farming resulting in more animal suffering.

UPSIDE Foods’ chicken is cultivated directly from animal cells. It’s not vegan or vegetarian – it’s delicious meat, made without the need to raise and slaughter billions of chickens. In fact, at full commercial scale, UPSIDE could use a small amount of animal cells to cultivate the same amount of poultry meat that could come from hundreds of thousands of traditionally farmed birds.

In regulatory terms, UPSIDE’s “No Questions” letter marks a major step towards a new era in meat production where Americans will soon have the opportunity to buy delicious chicken that’s grown directly from animal cells.

On top of all this, it’s projected that cultivated meat production at scale will use less water and land than conventionally-produced meat. And because it’s made in a controlled environment subject to high standards of testing for safety and quality control, it has the potential to help reduce the risk of harmful bacterial contamination.   

Advertisement

This announcement comes after a series of milestones as UPSIDE Foods approaches commercialization, including a $400M Series C placing their valuation at over $1 billion, the acquisition of cultivated seafood company Cultured Decadence, a partnership with three-Michelin starred chef Dominique Crenn, and the opening of its Engineering, Production, and Innovation Center (EPIC), one of the world’s most advanced cultivated meat production facilities. Next, UPSIDE Foods will continue to work with the USDA’s Food Safety and Inspection Service (FSIS) to secure the remaining approvals that are required before UPSIDE Foods’ cultivated chicken can be sold to consumers. More details on the timing of the launch will follow.

About UPSIDE Foods
Based in Berkeley, CA, UPSIDE Foods grows meat, poultry and seafood directly from animal cells. These products are not vegan or vegetarian—they are delicious meat, made without the need to raise and slaughter billions of animals. Founded as the world’s first cultivated meat company in 2015, UPSIDE Foods has achieved numerous industry-defining milestones, including being the first company to produce multiple species of meat (beef, chicken and duck). The company believes that people shouldn’t have to choose between the foods they love and a thriving planet, and is working to build a better food system with access to delicious, humane, and sustainable meat, poultry, and seafood. UPSIDE Foods has won various industry awards, including New York Times’ Good Tech Awards, FastCo’s Next Big Thing in Tech, and the Best and Brightest Companies to Work For in the Nation by the National Association for Business Resources. UPSIDE Foods has raised a total of $608 million, including from the Abu Dhabi Growth Fund (ADG), Baillie Gifford, Bill Gates, Cargill, Future Ventures, John Doerr, John Mackey, Kimbal and Christiana Musk, Future Ventures, Norwest, Richard Branson, Softbank, Temasek, Threshold, Tyson Foods, and others. For more information, please visit www.upsidefoods.com.

SOURCE UPSIDE Foods

Author

HUNGRY FOR MORE?

Discover a feast for your senses with our Food & Drink Blog, a tantalizing part of STM Daily News. Get the latest articles, recipes, and foodie news delivered straight to your inbox. Satisfaction guaranteed!

SIGN UP TO RECEIVE THE LATEST RECIPES & FOODIE NEWS, PLUS SOME EXCLUSIVE GOODIES!

We don’t spam! Read our privacy policy for more info.

Advertisement

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Lifestyle

Mac and Cheese Recall: Potential Spoilage Concerns Affect Products at Major Retailers

Published

on

mac and cheese
Image: Adobe Stock

Mac and Cheese Recall

In a recent announcement by the Food and Drug Administration (FDA), two types of macaroni and cheese products sold at major retailers have been recalled due to concerns over potential spoilage. The recall affects Reser’s American Classics Macaroni & Cheese and Reser’s American Classics Macaroni & Cheese White Cheddar, as part of a broader recall of Reser’s Fine Foods deli salads and refrigerated items.

Scope of the Recall

The affected macaroni and cheese varieties were distributed across five states: California, Illinois, Minnesota, North Dakota, and South Dakota. The specific “use by” dates for the recalled products are as follows:

  • Reser’s American Classics Macaroni & Cheese: Use by dates of September 14 and September 16, 2024.
  • Reser’s American Classics Macaroni & Cheese White Cheddar: Use by date of September 11, 2024.

In addition to the macaroni and cheese products, the recall includes a variety of other items such as potato salad, scalloped potatoes, pasta salad, corn, egg salad, spinach dip, gravy, and various desserts.

Cause of the Recall

According to the FDA, the potential spoilage was linked to “temperature abuse” during transportation, specifically due to a malfunctioning refrigeration unit on a trailer. A representative from Reser’s Fine Foods confirmed to FOX Business that the issue was isolated to a single truckload of product delivered to only one distributor location.

“The recall was initiated on July 29, 2024, and no affected products ever made it to the store shelves,” the representative stated. They further reassured consumers that any items purchased from stores are safe to consume.

Retailer Responses

Major retailers, including Safeway, Stop & Shop, and Walmart, which stock Reser’s macaroni and cheese products, have stated that their stores were not impacted by the recall. However, Target, another retailer selling the products, did not provide a comment when contacted by FOX Business.

Consumer Safety First

The FDA and Reser’s Fine Foods have stressed the importance of consumer safety in this situation. While the affected products have not reached store shelves, customers who may have purchased any items from the recalled batch are encouraged to check the packaging for the specified “use by” dates.

As always, consumers are advised to be vigilant about food safety and to report any concerns to their local health department or the FDA. For those who may have questions or require further information regarding this recall, contacting Reser’s Fine Foods directly or checking the FDA’s website can provide additional clarity.

In conclusion, while the recent recall raises concerns over food safety, companies and regulatory agencies are working diligently to ensure that consumers remain informed and protected. As the situation develops, staying updated through reliable sources is essential for maintaining food safety standards in your household.

Advertisement

Read the story on Fox Business.com: https://www.foxbusiness.com/lifestyle/mac-cheese-sold-major-retailers-recalled-potential-spoiling

At our core, we at STM Daily News, strive to keep you informed and inspired with the freshest content on all things food and beverage. From mouthwatering recipes to intriguing articles, we’re here to satisfy your appetite for culinary knowledge.

Visit our Food & Drink section to get the latest on Foodie News and recipes, offering a delightful blend of culinary inspiration and gastronomic trends to elevate your dining experience.

https://stmdailynews.com/food-and-drink/

Author

  • Rod Washington

    Rod: A creative force, blending words, images, and flavors. Blogger, writer, filmmaker, and photographer. Cooking enthusiast with a sci-fi vision. Passionate about his upcoming series and dedicated to TNC Network. Partnered with Rebecca Washington for a shared journey of love and art. View all posts


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

FDA CDC News

Important Recall Alert: Milo’s Poultry Farms and Tony’s Fresh Market Eggs Potentially Contaminated with Salmonella

Milo’s Poultry Farms, LLC has recalled eggs under the “Milo’s Poultry Farms” and “Tony’s Fresh Market” labels in Wisconsin, Illinois, and Michigan due to Salmonella contamination, advising consumers to discard or return products.

Published

on

selective focus photo of three eggs on tray
Photo by Monserrat Soldú on Pexels.com

As of September 6, 2024, Milo’s Poultry Farms, LLC, headquartered in Bonduel, Wisconsin, has issued a voluntary recall of all its egg products due to possible contamination with Salmonella. This recall applies to both “Milo’s Poultry Farms” and “Tony’s Fresh Market” branded eggs, spanning across various retail stores and foodservice distributors in Wisconsin, Illinois, and Michigan.


What You Need to Know

Salmonella is a bacteria that can cause serious and occasionally fatal infections, particularly in young children, the elderly, and individuals with weakened immune systems. Healthy individuals infected with Salmonella often experience fever, diarrhea (potentially bloody), nausea, vomiting, and abdominal pain. In severe cases, the infection can result in the bacteria entering the bloodstream and causing more critical conditions such as infected aneurysms, endocarditis, and arthritis.

@stmblog

🚨 Egg recall alert! Milo’s Poultry Farms is recalling eggs in WI, IL, & MI due to Salmonella. Please discard or return products ASAP! 🥚⚠️ ♬ original sound – STMDailyNews

Scope of the Recall

The recall encompasses:

  • All carton sizes and types of eggs under the “Milo’s Poultry Farms” label, across all expiration dates.
  • All carton sizes of “Tony’s Fresh Market” branded eggs, applicable to all expiration dates.
  • All cases of eggs intended for retail foodservice distribution, regardless of expiration dates.

Reason for the Recall

The recall was triggered after environmental samples collected by the FDA tested positive for Salmonella. Further investigations through whole genome sequencing linked these samples to an ongoing outbreak of Salmonella, prompting immediate action by Milo’s Poultry Farms.

Consumer Safety Measures

Milo’s Poultry Farms, LLC has temporarily halted production and distribution of the affected products to conduct necessary testing and sanitization processes at their facilities.

What Should Consumers Do?

Customers who have purchased any of the recalled eggs are strongly advised not to consume them. These products should be discarded immediately or returned to the place of purchase for a full refund.

Consumers with additional questions or concerns can reach out directly to Milo’s Poultry Farms, LLC at (715) 758-6709 for further guidance and support.

Stay Informed

Salmonella is an ongoing risk in uncooked poultry and eggs. Consumers are reminded to cook eggs thoroughly before consumption to kill bacteria and prevent illness. Stay updated with food recall alerts and safety guidelines to ensure the health and safety of you and your family.

Remember, food safety is paramount. Keep abreast of the latest FDA warnings and manufacturer recalls to safely navigate any potential health risks associated with contaminated products.

About the FDA

The Food and Drug Administration (FDA) is a U.S. federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. The FDA also regulates the nation’s food supply to safeguard against contamination and prevent foodborne illnesses. One of its key functions is monitoring and managing food recalls when potential risks are identified, ensuring that hazardous foods are quickly and effectively removed from the market. The FDA issues alerts to inform the public about foodborne illness outbreaks, working collaboratively with manufacturers to recall affected products and maintain the safety and integrity of the food supply chain.

Advertisement

Follow FDA

Read the FDA release here: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/milos-poultry-farms-llc-recalls-eggs-because-possible-health-risk

Source: FDA

Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.

STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.

https://stmdailynews.com/category/stories-this-moment

Authors


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

News

FDA Approves Game-Changing Nasal Spray for Anaphylaxis Treatment

Published

on

In a landmark decision on August 9, 2024, the U.S. Food and Drug Administration (FDA) approved the first-ever nasal spray, neffy, for the emergency treatment of severe allergic reactions, including anaphylaxis, in individuals weighing at least 30 kilograms (approximately 66 pounds). This approval marks a significant breakthrough in the management of life-threatening allergic reactions, offering a non-injectable form of epinephrine that could transform how patients handle emergency situations.

Nasal Spray
Man uses a nasal spray. Adobe Stock

Breaking Away from Injections: The Significance of Neffy

Traditionally, the treatment of anaphylaxis—a rapid and severe allergic reaction—has relied solely on injectable forms of epinephrine. This method, while effective, poses a challenge for many, particularly children who might fear needles, potentially delaying life-saving intervention. Neffy emerges as an innovative solution, providing epinephrine in a nasal spray form. As highlighted by Dr. Kelly Stone, MD, PhD, of the FDA’s Center for Drug Evaluation and Research, the development of neffy addresses an urgent need by removing the barrier of injection-associated anxiety and facilitating quicker, more accessible treatment.

The Science Behind Neffy

The approval of neffy was based on extensive clinical research involving 175 healthy adults. These studies explored the absorption and effect of neffy compared to traditional injectable epinephrine forms, focusing on indicators such as epinephrine concentration in the blood and the consequent physiological responses like changes in blood pressure and heart rate. The results confirmed that neffy delivers comparable epinephrine levels and physiological effects necessary for treating anaphylaxis effectively. Further research in children over 66 pounds mirrored these findings, showcasing neffy’s efficacy across different age groups.

How Neffy Works

Neffy is administered as a single dose via a nasal spray into one nostril. In cases where symptoms do not improve or worsen, a second dose may be applied using a new unit. It’s imperative for users to seek immediate medical attention after administering neffy to ensure comprehensive care and monitoring.

Considerations and Side Effects

While neffy stands as a revolutionary step forward, it comes with necessary precautions. Individuals with certain nasal conditions, such as nasal polyps or a history of nasal surgeries, may experience altered absorption rates. In such cases, traditional injectable products might be recommended. Users must also be cautious about potential side effects, which can include throat irritation, headache, nasal discomfort, and dizziness among others.

A Forward Leap in Allergy Management

With the introduction of neffy, patients and caregivers now have a less invasive option at their disposal. This development not only expands the tools available for combating severe allergic reactions but also significantly lowers the threshold for timely, effective intervention. The FDA’s fast-track designation of neffy underscores its potential impact, promising a new era of empowerment for those living with severe allergies.

In conclusion, the FDA’s approval of neffy represents a major advance in allergy care, highlighting ongoing innovation in medical treatments and patient care options. As neffy becomes available, it is poised to become a crucial asset in allergy management, enhancing safety and comfort for patients across the United States.

Advertisement

Source: FDA

https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis?utm_medium=email&utm_source=govdelivery

Our Lifestyle section on STM Daily News is a hub of inspiration and practical information, offering a range of articles that touch on various aspects of daily life. From tips on family finances to guides for maintaining health and wellness, we strive to empower our readers with knowledge and resources to enhance their lifestyles. Whether you’re seeking outdoor activity ideas, fashion trends, or travel recommendations, our lifestyle section has got you covered. Visit us today at https://stmdailynews.com/category/lifestyle/ and embark on a journey of discovery and self-improvement.

STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.

https://stmdailynews.com/category/stories-this-moment

Author

  • Hal Machina

    Hal Machina is a passionate writer, blogger, and self-proclaimed journalist who explores the intersection of science, tech, and futurism. Join him on a journey into innovative ideas and groundbreaking discoveries! View all posts journalist


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending